Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric S Kilpatrick

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Annals of Clinical Biochemistry|August 10, 2004
Hypopituitarism presenting as a mixed hyperlipidaemiaEric S Kilpatrick, Jane E Patmore, Christopher Rowland-Hill, et al.
Diabetes Care|May 1, 2007
Effects of isoflavone dietary supplementation on cardiovascular risk factors in type 2 diabetesSusana González, Vijay Jayagopal, Eric S Kilpatrick, et al.
Clinical Chemistry|March 15, 2023
Establishing Pragmatic Analytical Performance Specifications for Blood Beta-Hydroxybutyrate TestingEric S Kilpatrick, Alexandra E Butler, Stephen L Atkin, et al.
Diabetes, Obesity & Metabolism|May 25, 2021
The retinopathy-derived HbA1c threshold of 6.5% for type 2 diabetes also captures the risk of diabetic nephropathy in NHANESStephen L Atkin, Alexandra E Butler, Steven C Hunt, et al.
Biochemia Medica|December 31, 2020
Using clinical guidelines to assess the potential value of laboratory medicine in clinical decision-makingAllan J Hicks, Zoe L Carwardine, Mike J Hallworth, et al.
Clinical Endocrinology|October 20, 2018
Development of a novel risk prediction and risk stratification score for polycystic ovary syndromeHarshal Deshmukh, Maria Papageorgiou, Eric S Kilpatrick, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 25, 2014
Management of severe in-patient hyponatraemia: an audit in two teaching hospitals in Yorkshire, UKDeepa Narayanan, Wycliffe Mbagaya, Mo Aye, et al.
Clinical Endocrinology|September 22, 2016
Endocannabinoid receptor blockade increases vascular endothelial growth factor and inflammatory markers in obese women with polycystic ovary syndromeThozhukat Sathyapalan, Zeeshan Javed, Eric S Kilpatrick, et al.
The Journal of Clinical Endocrinology and Metabolism|August 11, 2012
Atorvastatin reduces malondialdehyde concentrations in patients with polycystic ovary syndromeThozhukat Sathyapalan, John Shepherd, Anne-Marie Coady, et al.
Journal of the Endocrine Society|December 22, 2017
Soy Protein Improves Cardiovascular Risk in Subclinical Hypothyroidism: A Randomized Double-Blinded Crossover StudyThozhukat Sathyapalan, Zeeshan Javed, Alan S Rigby, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Annals of Clinical Biochemistry|August 10, 2004
Hypopituitarism presenting as a mixed hyperlipidaemiaEric S Kilpatrick, Jane E Patmore, Christopher Rowland-Hill, et al.
Diabetes Care|May 1, 2007
Effects of isoflavone dietary supplementation on cardiovascular risk factors in type 2 diabetesSusana González, Vijay Jayagopal, Eric S Kilpatrick, et al.
Clinical Chemistry|March 15, 2023
Establishing Pragmatic Analytical Performance Specifications for Blood Beta-Hydroxybutyrate TestingEric S Kilpatrick, Alexandra E Butler, Stephen L Atkin, et al.
Diabetes, Obesity & Metabolism|May 25, 2021
The retinopathy-derived HbA1c threshold of 6.5% for type 2 diabetes also captures the risk of diabetic nephropathy in NHANESStephen L Atkin, Alexandra E Butler, Steven C Hunt, et al.
Biochemia Medica|December 31, 2020
Using clinical guidelines to assess the potential value of laboratory medicine in clinical decision-makingAllan J Hicks, Zoe L Carwardine, Mike J Hallworth, et al.
Clinical Endocrinology|October 20, 2018
Development of a novel risk prediction and risk stratification score for polycystic ovary syndromeHarshal Deshmukh, Maria Papageorgiou, Eric S Kilpatrick, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 25, 2014
Management of severe in-patient hyponatraemia: an audit in two teaching hospitals in Yorkshire, UKDeepa Narayanan, Wycliffe Mbagaya, Mo Aye, et al.
Clinical Endocrinology|September 22, 2016
Endocannabinoid receptor blockade increases vascular endothelial growth factor and inflammatory markers in obese women with polycystic ovary syndromeThozhukat Sathyapalan, Zeeshan Javed, Eric S Kilpatrick, et al.
The Journal of Clinical Endocrinology and Metabolism|August 11, 2012
Atorvastatin reduces malondialdehyde concentrations in patients with polycystic ovary syndromeThozhukat Sathyapalan, John Shepherd, Anne-Marie Coady, et al.
Journal of the Endocrine Society|December 22, 2017
Soy Protein Improves Cardiovascular Risk in Subclinical Hypothyroidism: A Randomized Double-Blinded Crossover StudyThozhukat Sathyapalan, Zeeshan Javed, Alan S Rigby, et al.
Pageof 13